Key Highlights
- Entact Bio appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer.
- Dr. Tommasi brings 30 years of drug discovery leadership across multiple therapeutic areas.
- Tommasi previously served at Dunad Therapeutics and Entasis Therapeutics, driving successful clinical outcomes.
- Entact Bio focuses on precision medicines that enhance beneficial protein function via the Encompass™ platform.
Source: Business Wire
Notable Quotes
- “We’re thrilled to welcome Ruben, who brings deep expertise in drug discovery and has a proven record in successfully advancing compounds from program inception to clinical development and regulatory approval.” — Victoria Richon, Ph.D., CEO at Entact Bio
- “I was very attracted to the innovative modality Entact is developing as it holds tremendous potential to pursue new, undrugged targets believed to be beneficial against disease.” — Ruben Tommasi, Ph.D., Chief Scientific Officer at Entact Bio
SoHC's Take
The appointment of Dr. Ruben Tommasi as Chief Scientific Officer marks a pivotal moment for Entact Bio. His extensive experience in drug discovery, particularly in progressing compounds through to FDA approval, will likely accelerate the development of Entact’s innovative ENTAC™ medicines. With a proven track record across multiple therapeutic areas, Dr. Tommasi’s leadership will strengthen the company’s ability to explore novel therapeutic targets and address diseases that current treatments cannot effectively reach. This strategic move positions Entact Bio to further expand its impact on precision medicine, potentially offering new hope to patients in underserved disease areas.
Heading
In this five-part fireside chat, Dr. Jim Bonnette breaks down the real-world challenges holding health plans back—from fragmented vendor strategies ...
Key Highlights New Mountain Capital is backing SmarterDx at a billion-dollar valuation, according to a source familiar with the transaction.SmarterDx ...
Episode Details: Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Navin Gupta, CEO at Viventium & Hadas Nahon, ...
Episode Details Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio. What you'll get out of ...
Key Highlights Babson Diagnostics partners with Sam’s Clubto expand BetterWay™ blood testingSeven Austin-area Sam’s Club pharmaciesto offer testing, starting with ...
Key Highlights Jeannette Bankes appointed President & CEO, Patient Care SolutionsEffective May 1, 2025, following Tom Westrick’s retirementBrings 30 years of ...
